Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.
about
Calcium channel blockers for people with chronic kidney disease requiring dialysisInterdialytic ambulatory blood pressure in patients with intradialytic hypertensionRecent advances in the management of hemodialysis patients: a focus on cardiovascular diseaseHigh blood pressure in dialysis patients: cause, pathophysiology, influence on morbidity, mortality and managementManagement of Patient Care in Hemodialysis While Focusing on Cardiovascular Disease Events and the Atypical Role of Hyper- and/or Hypotension: A Systematic ReviewRelationship between Hemoglobin Levels Corrected by Interdialytic Weight Gain and Mortality in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort StudyEpidemiology, diagnosis and management of hypertension among patients on chronic dialysis.Pharmacotherapy of end-stage renal disease.Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis.Association of adipokines with blood pressure, arterial elasticity and cardiac markers in dialysis patients: cross-sectional analysis of baseline data from a cohort study.Blood pressure and mortality among hemodialysis patientsShort daily versus conventional hemodialysis for hypertensive patients: a randomized cross-over study.Prevalence of cardiovascular risk factors in hemodialysis patients - The CORDIAL studyRelationship between microRNA-146a expression and plasma renalase levels in hemodialyzed patients.Assessment and management of hypertension in patients on dialysis.Systolic blood pressure and mortality in patients on hemodialysis.Influence of the use of phosphate binders on serum levels of calcium phosphate in patients with chronic kidney disease undergoing hemodialysis: A retrospective and prospective study.Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) StudyAntihypertensive agents in hemodialysis patients: a current perspective.The effects of an interventional program based on self-care model on health-related quality of life outcomes in hemodialysis patients.Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.Hypertension in chronic kidney disease: navigating the evidence.Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patientsToward a definition of masked hypertension and white-coat hypertension among hemodialysis patients.Strategies to improve physical activity by exercise training in patients with chronic kidney disease.Improvement of resistant hypertension by nocturnal hemodialysis in a patient with end-stage kidney diseaseEpidemiology of interdialytic ambulatory hypertension and the role of volume excess.Body mass index-mortality paradox in hemodialysis: can it be explained by blood pressure?Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials.Association of Processed Meat Intake with Hypertension Risk in Hemodialysis Patients: A Cross-Sectional Study.Long-term effects of aliskiren on blood pressure and the renin-angiotensin-aldosterone system in hypertensive hemodialysis patientsMathematical modeling the neuroregulation of blood pressure using a cognitive top-down approachOptimal blood pressure level and best measurement procedure in hemodialysis patients.Home systolic blood pressure on the morning of dialysis days has prognostic impact for hypertensive hemodialysis patientsEffect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis.Predictors of blood pressure and its control in pediatric patients receiving dialysis.Cardiovascular risk in chronic renal disease and transplantation prevention and management.The effect of low-sodium dialysate on ambulatory blood pressure measurement parameters in patients undergoing hemodialysisPractical ways to deal with the high burden of cardiovascular disease in hemodialysis patients.
P2860
Q24197656-655B1D7F-E6A7-476C-8078-62A1CE9689FBQ26824129-02AD8B4B-CD01-4AF2-A469-3548E90E3937Q26849298-8F566384-1897-4F1F-86A5-AFF7CFF7A7B8Q26861624-9F2986C6-0D90-49C4-868D-A0A65DD03FE8Q28079673-770A7D4D-5CEC-4314-A780-B9D981F6951DQ28468446-F0EB11F2-01B0-4452-AD6F-8A65BE63A3DBQ30248239-DEA87111-5746-40A6-BB1D-B138256F8701Q33531889-0A200093-C0DF-4BC2-9FB0-3C3AEEF6153DQ33615328-E5935D10-4E6F-41CF-9522-1D5A579A2A29Q33655226-A0101A48-B9A8-4D2C-B8A9-748BCC78131BQ33672511-EA0D2147-FF39-45C0-8D1C-F07DDEBD3C08Q33686240-724963D1-74EE-4F1E-A205-54D6C6308783Q33733420-BBDB114F-8BB6-4D54-AE1A-FA1D76CCD5C7Q33797472-5E90BCFD-5864-45C0-B3FB-B0B435964789Q33974561-BBEE9E8F-9E50-4BB1-B68D-D888FE531FF5Q34020784-7FAD8291-57A5-443E-B053-EA5E27A70FE2Q34080416-0CDD07EE-2D66-4192-A4F8-5D33BEB9AB30Q34084375-27F5DAFA-3C8C-4671-A119-FAD80F0A4FBBQ34700870-C5C0B45F-29FB-4E49-BB67-481C6CEEB21CQ34767249-E6402349-001B-4321-A1E8-28E5EE0A77E1Q35025436-6DFCF91B-3D8C-4CCA-AA5F-429893CC3957Q35030572-08C1B22E-0479-44D5-B6D9-C3E84C210194Q35071147-F01D03DB-3DFC-4FD0-87A4-2DF27ACB0748Q35148164-0D0C0088-4574-40E1-9B22-E67B9AD715E2Q35165529-342F20A6-A59D-4DC9-A50A-53C9592ABB93Q35185737-38E4F73E-2D44-4431-BAF0-97E924D472BBQ35225345-1EFCEA5A-D9DA-407C-8D7C-7EF56FCF2878Q35237459-A853F8FB-AAE8-4B09-86E7-BDC26B24F596Q35621936-B03E837F-6B3C-4CCA-86B0-9512F40AE779Q35812096-3AE44F4C-3B8F-4EF8-AEAF-FC41542D3460Q35827489-9AE8AC55-24E0-46CA-A2D2-215297B5D7C9Q35905903-F850139E-7140-4F0B-95BD-5981C638FED7Q35919148-B6C171FC-11A5-4699-9ADE-C81F49553AA4Q36012839-B8CB71B6-33F9-4445-A141-5FA578A1F55CQ36035665-8CEFBA41-3F3A-4DD8-B562-5EF7930855F8Q36090656-4E37DE6E-152A-41CC-B13A-1401D1DB5AD7Q36132453-A1040FF6-CC60-4C4A-AB83-703902035425Q36161264-0EED4054-ED4D-4E0D-B368-B19AB7884FAFQ36389743-3E38767E-89A4-4E81-AD3B-1E4284B69A3BQ36448347-59BD9781-6A83-4E37-A304-0BE494B68F3B
P2860
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Prevalence, treatment, and con ...... patients in the United States.
@en
Prevalence, treatment, and con ...... patients in the United States.
@nl
type
label
Prevalence, treatment, and con ...... patients in the United States.
@en
Prevalence, treatment, and con ...... patients in the United States.
@nl
prefLabel
Prevalence, treatment, and con ...... patients in the United States.
@en
Prevalence, treatment, and con ...... patients in the United States.
@nl
P2093
P1476
Prevalence, treatment, and con ...... patients in the United States.
@en
P2093
Allen R Nissenson
Daniel Batlle
Daniel W Coyne
David G Warnock
J Richard Trout
Rajiv Agarwal
P304
P356
10.1016/S0002-9343(03)00366-8
P407
P577
2003-09-01T00:00:00Z